With cases of atrial fibrillation and other heart rhythm disorders rising rapidly, the European Heart Rhythm Association (EHRA) calls for greater awareness and early detection—starting with a simple pulse check on 1 March....
Noor to lead strategy, M&A, and innovation initiatives, including integration of Paragon 28 acquisition. ...
Collaboration brings clinical-grade magnetoencephalography (MEG) technology to consumers, launching first brain health center in London....
At ECR 2025, the two companies unveil the next phase of their research program, developing scalable urine filtration systems to reduce contrast media waste and promote circular sustainability in hospital radiology....
New real-time, self-adjusting deep brain stimulation system transforms Parkinson’s care with personalized neuromodulation...
With CE Mark approval, CathVision’s AI-powered ECGenius System is set to launch in the European market, enhancing real-time electrogram recording and clinical decision-making for healthcare providers....
The new 2 mL pre-filled pen option expands individualized treatment choices for hereditary angioedema (HAE) patients, reinforcing Takeda’s commitment to reducing disease burden and improving quality of life....
The strategic collaboration will introduce Eau Thermale Avène and Ducray dermo-cosmetic brands to Kenya, Tanzania, and Uganda, addressing the growing demand for high-quality dermatological solutions in the region....
With plans to commercialize its pancreatic cancer test in the U.S. by late 2025, Immunovia seeks financial leadership with diagnostics expertise and global capital market experience....
With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe. ...